Our data showed that FBLN2 DNA was methylated in the promoter region in most of the lung cancer cell lines displaying downregulated FBLN2, implying that DNA methylation is a frequent epigenetic event partially responsible for FBLN2 gene silencing. The gene discussed is FBLN2; the disease is lung carcinoma.